Site Sponsors
  • Strem Chemicals - Nanomaterials for R&D
  • Oxford Instruments Nanoanalysis - X-Max Large Area Analytical EDS SDD
  • Park Systems - Manufacturer of a complete range of AFM solutions
Posted in | Bionanotechnology

NWU to Study Nano-Entrapment Technology-Based Phytofare Topical Cream

Published on September 6, 2013 at 4:25 AM

Plandaí Biotechnology, Inc., a producer of highly bioavailable plant extracts for industries including health, wellness, nutriceutical, and pharmaceutical, today announced that it has engaged North-West University, a leading medical research facility in Potchefstroom, South Africa, to conduct several clinical studies involving Phytofare™ Pheroid™ Topical Catechin Complex ("ph2TM"), a new topical cream based on the nano-entrapment technology developed by Prof. Anne Grobler at NWU and recently licensed to Plandaí for human and animal use.

The first of two commissioned studies, which commenced August 30, 2013, will test the moisturizing effects of Phytofare™ Pheroid™ Topical Catechin Complex on 35 human volunteers. A second study, also commenced August 30th on 35 human subjects, is testing the anti-inflammatory benefits of the product. A third human study will start later in the year to explore the anti-aging properties of Phytofare™ Pheroid™ Topical Catechin Complex. The topical cream is expected to be marketed as an ingredient in various skin care products.

The Pheroid™ technology, developed in conjunction with North-West University, allows Phytofare™ particles to be entrapped in a long-chain fatty acid, which has been previously shown to enhance absorption in both topical and oral preparations.

Roger Duffield, Chairman and Chief Executive Officer of Plandaí Biotechnology, commented, "We are enthusiastic about the potential for ph2TM Topical Catechin Complex in the nutriceutical market space. We've fielded multiple inquiries from large skin care product manufacturers interested in seeing the known benefits of green tea catechins transferred into a topical solution that can penetrate through the various tissue levels and be absorbed at the cellular level. We envision this product being incorporated into products ranging from skin rejuvenation to anti-aging to after shave."

The trials are expected to take approximately three months leading up to anticipated market release during the first quarter of 2014.

About Plandaí Biotechnology, Inc.

Plandaí Biotechnology, Inc. and its subsidiaries develop highly bioavailable, phytonutrient rich extracts which are being utilized to deliver a new family of drugs to safely and affordably treat a multitude of diseases and conditions. Plandaí Biotechnology controls every aspect of the process, from growing the raw materials on its farms in South Africa, to producing its patented Phytofare™ extracts in-house, allowing the Company to guarantee the continuity of supply as well as quality control throughout the entire process. Targeted industries for the Company's products include beverage, cosmeceutical, wellness, nutraceutical, anti-aging, and pharmaceutical.

Source: http://www.plandaibiotech.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Submit